Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyka Labs is an established Indian pharmaceutical company primarily engaged in the development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company is widely recognized for its specialized capabilities in lyophilization technology, producing a significant range of sterile injectable products. Its therapeutic focus includes anti-infectives, dermatology, cardiovascular health, and pain management. Lyka Labs operates manufacturing facilities that comply with international standards and provides contract manufacturing services to global pharmaceutical firms. Following a strategic investment, the company operates as a subsidiary of Ipca Laboratories, leveraging a broader distribution network and enhanced R&D resources. The company maintains a strong presence in both the Indian domestic market and various international territories across Africa, South East Asia, and Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyka.